跳至主要内容
临床试验/NCT03379571
NCT03379571已完成不适用

Competing Risk of Death and End-stage Renal Disease in Incident Chronic Kidney Disease (Stages 3 to 5): the EPIRAN Community-based Study

Central Hospital, Nancy, France0 个研究点目标入组 631 人开始时间: 2004年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
631
主要终点
annual incidence rate of CKD

研究概览

简要总结

Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed.

Methods: From a community-based sample of 4,409 individuals residing in a well-defined geographical area, investigators determined the number of patients having a first serum creatinine value ≥1.7 mg/dL and present for at least 3 months that allowed us to calculate an annual incidence rate of CKD (stages 3 to 5). CKD (stages 3 to 5) was defined by estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. Investigators also described the primary care, outcomes and risk factors associated with outcomes using competing risks analyses for these CKD patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >= 18 years
  • first serum creatinine value ≥1.7 mg/dL reached after January 1st, 2004
  • and present for at least 3 months
  • residing in the given geographical area (the Urban Community of Greater Nancy (UCGN))

排除标准

  • <18 years
  • prevalent CKD patient : CKD diagnosis before January 1st, 2004
  • patients on dialysis or renal transplanted
  • refusal of participation

结局指标

主要结局

annual incidence rate of CKD

时间窗: inclusion

number of patients residing in a well-defined geographical area having a first serum creatinine value ≥1.7 mg/dL after January 1st, 2004 and still present for at least 3 months

次要结局

  • dialysis initiation(through study completion, 6 year after study start)
  • death(through study completion, 6 year after study start)
  • management of CKD patients(through study completion, 6 year after study start)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

相似试验